Skip to main content
Clinical Trials/NCT06201988
NCT06201988
Not yet recruiting
Not Applicable

Assessing Patient Engagement and Understanding in Hepatic Encephalopathy Clinical Research

Power Life Sciences Inc.1 site in 1 country500 target enrollmentJanuary 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hepatic Encephalopathy
Sponsor
Power Life Sciences Inc.
Enrollment
500
Locations
1
Primary Endpoint
Number of hepatic encephalopathy patients who remain in clinical trial until completion
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.

In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.

Registry
clinicaltrials.gov
Start Date
January 2025
End Date
January 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed Written Informed Consent
  • Aged ≥ 18 years old
  • No prior treatment for hepatic encephalopathy

Exclusion Criteria

  • Participant is actively receiving study therapy in another
  • Inability to provide written informed consent
  • Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Outcomes

Primary Outcomes

Number of hepatic encephalopathy patients who remain in clinical trial until completion

Time Frame: 12 months

Rate of patients who decide to join in a hepatic encephalopathy clinical trial

Time Frame: 3 months

Study Sites (1)

Loading locations...

Similar Trials